Skip to main content
Livermore
Livermore
ZHEN

ProShare Advisors LLC

SEC CIK
0001357955
Latest filing
Aug 11, 2026

RPRX holding history

Royalty Pharma plc in every 13F filed by ProShare Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RPRX overviewAll 13F holders of RPRXFull Q2 2026 holdings

Shares (Q2 2026)
14,542
Value
$815.4K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of RPRX by ProShare Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202614,542$815.4K<0.1%−4,623−24.1%ReducedHolders
Q1 202619,165$919.3K<0.1%+294+1.6%AddedHolders
Q4 202518,871$729.2K<0.1%+3,462+22.5%AddedHolders
Q3 202515,409$543.6K<0.1%−332−2.1%ReducedHolders
Q2 202515,741$567.1K<0.1%−3,807−19.5%ReducedHolders
Q1 202519,548$608.5K<0.1%−1,495−7.1%ReducedHolders
Q4 202421,043$536.8K<0.1%−5,438−20.5%ReducedHolders
Q3 202426,481$749.1K<0.1%−1,366−4.9%ReducedHolders
Q2 202427,847$734.3K<0.1%−3,458−11.0%ReducedHolders
Q1 202431,305$950.7K<0.1%+2,764+9.7%AddedHolders
Q4 202328,541$801.7K<0.1%−807−2.7%ReducedHolders
Q3 202329,348$796.5K<0.1%+348+1.2%AddedHolders
Q2 202329,000$891.5K<0.1%−1,724−5.6%ReducedHolders
Q1 202330,724$1.11M<0.1%−11,377−27.0%ReducedHolders
Q4 202242,101$1.66M<0.1%−501−1.2%ReducedHolders
Q3 202242,602$1.71M<0.1%+2,778+7.0%AddedHolders
Q2 202239,824$1.67M<0.1%−13,142−24.8%ReducedHolders
Q1 202252,966$2.06M<0.1%−16,469−23.7%ReducedHolders
Q4 202169,435$2.77M<0.1%−30,176−30.3%ReducedHolders
Q3 202199,611$3.60M<0.1%+25,899+35.1%AddedHolders
Q2 202173,712$3.02M<0.1%+18,398+33.3%AddedHolders
Q1 202155,314$2.41M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.